Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07075341
Recruiting
Healthy Living BEYOND Weight Study
Not applicable · United States · 1 site
Registry update: 28 Oct 2026
NCT07054515
Recruiting
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Phase 3 · Argentina, Australia, Brazil, Canada, Switzerland, Germany, Spain, France, United Kingdom, India, Italy, Mexico, Pakistan, Portugal, Sweden, United States · 39 sites
Registry update: 27 Oct 2026
NCT07116213
Recruiting
Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer
Not applicable · China · 1 site
Registry update: 16 Sept 2026
NCT07159971
Recruiting
Family-Based Nutrition Intervention to Prevent Overweight and Obesity in School-Age Children.
Not applicable · Mexico · 1 site
Registry update: 7 Oct 2026
NCT07075731
Recruiting
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
Not applicable · United States · 1 site
Registry update: 16 Jul 2026
NCT06572345
Recruiting
Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study
Not applicable · United Kingdom · 1 site
Registry update: 9 Jul 2026
NCT06840834
Recruiting
Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy
Phase 2 · France · 21 sites
Registry update: 10 Aug 2026
Conflicting statuses (not updated in the registry for 3 months)
NCT06627764
Recruiting
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families
Not applicable · United States · 1 site
Registry update: 16 Oct 2026
NCT07770113
Recruiting
A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer
Phase 2 · China · 1 site
Registry update: 18 Aug 2026
NCT07019259
Recruiting
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
Not applicable · United States · 2 sites
Registry update: 12 Jun 2026
NCT07052578
Recruiting
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
Not applicable · Russia · 24 sites
Registry update: 22 Oct 2026
NCT07259512
Recruiting
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
Phase 4 · Indonesia · 1 site
Registry update: 10 Dec 2025
NCT07771803
Recruiting
A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
Early phase 1 · United States · 1 site
Registry update: 18 Aug 2026
NCT06486883
Recruiting
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
Phase 2 · Austria, Belgium, Germany, Spain, France, United Kingdom, Italy, Netherlands, Poland, Portugal · 87 sites
Registry update: 30 Jul 2026
NCT07037862
Recruiting
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
Phase 1/2 · Belgium, Germany, Spain, France, United Kingdom, Ireland, Italy, Poland · 21 sites
Registry update: 13 Aug 2026
NCT06979375
Recruiting
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
Phase 2 · Australia, Czechia, Germany, Spain, United Kingdom, India, Japan, South Korea, Netherlands, Poland · 85 sites
Registry update: 11 Mar 2026
Conflicting statuses (not updated in the registry for 8 months)
NCT07657624
Recruiting
Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease
Not applicable · China · 1 site
Registry update: 15 Jul 2026
NCT06982794
Recruiting
A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
Not applicable · Italy · 1 site
Registry update: 21 May 2025
NCT07013916
Recruiting
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
Not applicable · United Kingdom · 2 sites
Registry update: 31 Jul 2026
NCT06962865
Recruiting
A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC
Phase 2 · China · 34 sites
Registry update: 16 Jul 2025

Ordered by registry start date. Freshness and sponsorship never change the order.